Second malignant neoplasms following hematopoietic stem cell transplantation

被引：21

作者：

Friedman, DL ^{[1
]}

Leisenring, W ^{[1
]}

Schwartz, JL ^{[1
]}

Deeg, HJ ^{[1
]}

机构：

[1] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2004年 / 79卷 / 03期

关键词：

posttransplantation malignancies; secondary cancers;

D O I：

10.1532/IJH97.03178

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

Hematopoietic stem cell transplantation is being successfully used to treat a variety of malignant and nonmalignant disorders. This therapy has resulted in an increasing number of survivors who are at risk for adverse long-term outcomes, including the development of second and subsequent malignant neoplasms. We review the incidence and spectrum of posttransplantation malignancies and discuss risk factors and future directions for research. (C) 2004 The Japanese Society of Hematology.

引用

页码：229 / 234

页数：6

共 23 条

[1]

André M, 1998, BLOOD, V92, P1933

[2]

Trends and advances in cancer survivorship research: Challenge and opportunity [J].

Aziz, NM ;

Rowland, JH .

SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (03) :248-266

[3]

New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors [J].

Baker, KS ;

Defor, TE ;

Burns, LJ ;

Ramsay, NKC ;

Neglia, JP ;

Robison, LL .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1352-1358

[4]

Malignant neoplasms following bone marrow transplantation [J].

Bhatia, S ;

Ramsay, NKC ;

Steinbuch, M ;

Dusenbery, KE ;

Shapiro, RS ;

Weisdorf, DJ ;

Robison, LL ;

Miller, JS ;

Neglia, JP .

BLOOD, 1996, 87 (09) :3633-3639

[5]

Solid cancers after bone marrow transplantation [J].

Bhatia, S ;

Louie, AD ;

Bhatia, R ;

O'Donnell, MR ;

Fung, H ;

Kashyap, A ;

Krishnan, A ;

Molina, A ;

Nademanee, A ;

Niland, JC ;

Parker, PA ;

Snyder, DS ;

Spielberger, R ;

Stein, A ;

Forman, SJ .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) :464-471

[6]

Solid cancers after bone marrow transplantation [J].

Curtis, RE ;

Rowlings, PA ;

Deeg, HJ ;

Shriner, DA ;

Socie, G ;

Travis, LB ;

Horowitz, MM ;

Witherspoon, RP ;

Hoover, RN ;

Sobocinski, KA ;

Fraumeni, JF ;

Boice, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :897-904

[7]

Deeg HJ, 1998, BLOOD, V91, P3637

[8]

RISK-FACTORS FOR THE DEVELOPMENT OF SECONDARY MALIGNANCIES AFTER MARROW TRANSPLANTATION [J].

DEEG, HJ ;

WITHERSPOON, RP .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :417-429

[9]

Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients [J].

Deeg, HJ ;

Socie, G ;

Schoch, G ;

HenryAmar, M ;

Witherspoon, RP ;

Devergie, A ;

Sullivan, KM ;

Gluckman, E ;

Storb, R .

BLOOD, 1996, 87 (01) :386-392

[10]

Malignancies after hematopoietic stem cell transplantation:: Many questions, some answers [J].

Deeg, HJ ;

Socié, G .

BLOOD, 1998, 91 (06) :1833-1844

← 1 2 3 →